In this double-masked study , patients were randomised to : @ mg IVT-AFL every @weeks ( @ q@ ) ; @mg IVT-AFL every @weeks ( @q@ ) ; @mg IVT-AFL every @weeks ( @q@ ) after @ monthly injections ; or @ mg ranibizumab every @weeks ( Rq@ ) .